Moderna is a biotechnology company focused on creating medicines using messenger RNA (mRNA) technology. Their core business model revolves around developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases. The company's primary revenue stream is from the sale of its COVID-19 vaccine, Spikevax, and they are working to expand their product portfolio into other areas. Moderna has a global presence with operations in North America, Europe, and Asia-Pacific.